- A randomized double-blind controlled trial found post-exposure prophylaxis with hydroxychloroquine (HCQ) was not advantageous for the prevention of COVID-19 in asymptomatic individuals with high risk for SARS-CoV-2 infection. The incidence of COVID-19 was similar in both the HCQ group and control. https://www.nature.com/articles/s41598-022-26053-w 179 comments science
Linked pages
- Increased Pediatric Respiratory Syncytial Virus Case Counts Following the Emergence of Severe Acute Respiratory Syndrome Coronavirus 2 Can Be Attributed to Changes in Testing | Clinical Infectious Diseases | Oxford Academic https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab638/6324310?redirectedFrom=fulltext 5618 comments
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/nejmoa2016638 161 comments
- Creative Commons — Attribution 4.0 International — CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ 95 comments
- WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data https://covid19.who.int/ 23 comments
- Clinical Characteristics of Coronavirus Disease 2019 in China | NEJM https://www.nejm.org/doi/full/10.1056/nejmoa2002032 7 comments
- Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2107934 5 comments
- Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2116044 2 comments